Inhibition of AcpA Phosphatase Activity with Ascorbate Attenuates Francisella tularensis Intramacrophage Survival
Autor: | John S. Gunn, Claudio F. Gonzalez, Nrusingh P. Mohapatra, Steven McRae, Fernando A. Pagliai, Asma Sayed Abdelgeliel Mahmou, Alejandro Gener, Graciela L. Lorca |
---|---|
Rok vydání: | 2010 |
Předmět: |
Phosphatase
Ascorbic Acid Biochemistry Antioxidants Microbiology Tularemia Mice Bacterial Proteins Catalytic Domain medicine Animals Francisella tularensis Molecular Biology Microbial Viability biology Macrophages Mutagenesis Acid phosphatase Cell Biology medicine.disease biology.organism_classification Ascorbic acid Phosphoric Monoester Hydrolases In vitro Enzymology biology.protein Francisella Gene Deletion |
Zdroj: | Journal of Biological Chemistry. 285:5171-5177 |
ISSN: | 0021-9258 |
DOI: | 10.1074/jbc.m109.039511 |
Popis: | Acid phosphatase activity in the highly infectious intracellular pathogen Francisella tularensis is directly related with the ability of these bacteria to survive inside host cells. Pharmacological inactivation of acid phosphatases could potentially help in the treatment of tularemia or even be utilized to neutralize the infection. In the present work, we report inhibitory compounds for three of the four major acid phosphatases produced by F. tularensis SCHU4: AcpA, AcpB, and AcpC. The inhibitors were identified using a catalytic screen from a library of chemicals approved for use in humans. The best results were obtained against AcpA. The two compounds identified, ascorbate (K(i) = 380 +/- 160 microM) and 2-phosphoascorbate (K(i) = 3.2 +/- 0.85 microM) inhibit AcpA in a noncompetitive, nonreversible fashion. A potential ascorbylation site in the proximity of the catalytic pocket of AcpA was identified using site-directed mutagenesis. The effects of the inhibitors identified in vitro were evaluated using bioassays determining the ability of F. tularensis to survive inside infected cells. The presence of ascorbate or 2-phosphoascorbate impaired the intramacrophage survival of F. tularensis in an AcpA-dependent manner as it was probed using knockout strains. The evidence presented herein indicated that ascorbate could be a good alternative to be used clinically to improve treatments against tularemia. |
Databáze: | OpenAIRE |
Externí odkaz: |